Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges

被引:7
|
作者
Yang, Wenzhan [1 ]
Saboo, Sugandha [1 ]
Zhou, Liping [1 ]
Askin, Sean [2 ]
Bak, Annette [1 ]
机构
[1] AstraZeneca, Adv Drug Delivery, Pharmaceut Sci, R&D, Boston, MA 02451 USA
[2] AstraZeneca, Adv Drug Delivery, Pharmaceut Sci, R&D, Cambridge, England
关键词
drug delivery; PROTAC; drug discovery; lipid-based formulations (LBF); amorphous solid dispersions (ASDs); LIPID-BASED FORMULATIONS; WATER-SOLUBLE DRUGS; PRECIPITATION INHIBITORS; CYCLOSPORINE-A; SYSTEMS; ABSORPTION; BIOAVAILABILITY; CLASSIFICATION; SOLUBILITY; PERMEABILITY;
D O I
10.1016/j.drudis.2023.103865
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PROteolysis TArgeting Chimeras (PROTACs) offer new opportunities in modern medicine by targeting proteins that are intractable to classic inhibitors. Heterobifunctional in nature, PROTACs are small molecules that offer a unique mechanism of protein degradation by hijacking the ubiquitin-mediated protein degradation pathway, known as the ubiquitin-proteasome system. Herein, we present an analysis on the structural characteristics of this novel chemical modality. Furthermore, we review and discuss the formulation opportunities to overcome the oral delivery challenges of PROTACs in drug discovery.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Challenges and opportunities in the delivery of cancer therapeutics
    Richard, Joel
    THERAPEUTIC DELIVERY, 2011, 2 (01) : 107 - 121
  • [42] Inner ear delivery: Challenges and opportunities
    Szeto, Betsy
    Chiang, Harry
    Valentini, Chris
    Yu, Michelle
    Kysar, Jeffrey W.
    Lalwani, Anil K.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (01): : 122 - 131
  • [43] Challenges and opportunities for circRNA identification and delivery
    Dong, Jiani
    Zeng, Zhuoer
    Huang, Ying
    Chen, Chuanpin
    Cheng, Zeneng
    Zhu, Qubo
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 58 (01) : 19 - 35
  • [44] Mobile Video Delivery: Challenges and Opportunities
    Panta, Rajesh Krishna
    IEEE INTERNET COMPUTING, 2015, 19 (03) : 64 - 67
  • [45] Challenges, opportunities, and therapeutic potential of JAK inhibitors and their derived PROTACs (2022-2023)
    Shah, Rishi R.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025,
  • [46] Ant genomics (Hymenoptera: Formicidae): challenges to overcome and opportunities to seize
    Nygaard, Sanne
    Wurm, Yannick
    MYRMECOLOGICAL NEWS, 2015, 21 : 59 - 72
  • [47] Some WebRTC opportunities for RCS And some inner challenges to overcome
    Romain, Carbou
    2013 17TH INTERNATIONAL CONFERENCE ON INTELLIGENCE IN NEXT GENERATION NETWORKS (ICIN), 2013, : 31 - 38
  • [48] The challenges of drug delivery to the esophagus and how to overcome them
    Krause, Julius
    Brokmann, Friederike
    Rosenbaum, Christoph
    Weitschies, Werner
    EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (02) : 119 - 131
  • [49] Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
    Kirtane, Ameya R.
    Kalscheuer, Stephen M.
    Panyam, Jayanth
    ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (13-14) : 1731 - 1747
  • [50] Oral history in medicine - challenges and opportunities
    Soehner, Felicitas
    Hansson, Nils
    Halling, Thorsten
    NTM, 2024, : 39 - 51